Latest Stories
Heartland Express (HTLD): Buy, Sell, or Hold Post Q3 Earnings?
Heartland Express trades at $10.36 per share and has stayed right on track with the overall market, gaining 14.4% over the last six months. At the same time, the S&P 500 has returned 11.3%.
Norfolk Southern (NSC): Buy, Sell, or Hold Post Q3 Earnings?
Norfolk Southern trades at $287.63 per share and has stayed right on track with the overall market, gaining 9.4% over the last six months. At the same time, the S&P 500 has returned 11.3%.
Kennametal (KMT): Buy, Sell, or Hold Post Q3 Earnings?
Kennametal has had an impressive run over the past six months as its shares have beaten the S&P 500 by 24.9%. The stock now trades at $33.28, marking a 36.2% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Quest trades at $179.96 and has moved in lockstep with the market. Its shares have returned 6.9% over the last six months while the S&P 500 has gained 11.3%.
3 Reasons to Sell ALSN and 1 Stock to Buy Instead
Since January 2021, the S&P 500 has delivered a total return of 83.7%. But one standout stock has nearly doubled the market - over the past five years, Allison Transmission has surged 156% to $105.96 per share. Its momentum hasn’t stopped as it’s also gained 16.8% in the last six months, beating the S&P by 5.6%.
3 Big Reasons to Love Warby Parker (WRBY)
Warby Parker’s 26.4% return over the past six months has outpaced the S&P 500 by 15.1%, and its stock price has climbed to $29.08 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
Solventum trades at $79.45 per share and has stayed right on track with the overall market, gaining 7.3% over the last six months. At the same time, the S&P 500 has returned 11.3%.
3 Reasons KMX is Risky and 1 Stock to Buy Instead
CarMax has gotten torched over the last six months - since July 2025, its stock price has dropped 29.3% to $46.12 per share. This might have investors contemplating their next move.
3 Reasons to Avoid MED and 1 Stock to Buy Instead
Over the past six months, Medifast’s stock price fell to $11.62. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 11.3%. This might have investors contemplating their next move.
3 Reasons to Avoid FIBK and 1 Stock to Buy Instead
First Interstate BancSystem’s 16.5% return over the past six months has outpaced the S&P 500 by 5.3%, and its stock price has climbed to $36.48 per share. This performance may have investors wondering how to approach the situation.